Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients

Cancer patients are considered as highly vulnerable to COVID-19 pandemic. However, delaying cancer specific therapies could have a deleterious effect on survival. The potential suppressive effects of chemotherapies or cancer-related microenvironment raised the question on how cancer patients ’ immune system responds to SARS-CoV-2 virus.

Source: European Journal of Cancer - March 26, 2021 Category: Cancer & Oncology Authors: Laura Mansi, Laurie Spehner, Etienne Daguindau, Kevin Bouiller, Hamadi Almotlak, Ulrich Stein, Adeline Bouard, Stefano Kim, Elodie Klajer, Marine Jary, Guillaume Meynard, Ang élique Vienot, Charlée Nardin, Fernando Bazan, Quentin Lepiller, Virginie West Tags: Current Perspective Source Type: research